Data / Drug companies / Anubis Cosmetics SL
Anubis Cosmetics SL: 20 products in the FDA NDC directory, labeler code 83021
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Anubis Cosmetics SL (labeler code 83021) lists 20 products in the FDA National Drug Code Directory. By type: 20 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on January 13, 2023.
The request: Watch Anubis Cosmetics SL (FDA labeler code 83021): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 83021
- Products in commercial distribution
- 20
- Packages
- 20
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 20
- Flagged as original packager
- 20 of 20 products that carry the flag
- Started marketing in the last 12 months
- 0
- Products with a marketing end date set
- 20
- Earliest marketing start
- October 13, 2022
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 20 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 20 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Concentrate | 7 | 35% |
| Cream | 7 | 35% |
| Liquid | 3 | 15% |
| Lotion | 3 | 15% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Anubis Barcelona | 83021-553 | Cream | Over the counter monograph drugs | January 13, 2023 |
| Anubis Barcelona | 83021-546 | Concentrate | Over the counter monograph drugs | January 13, 2023 |
| AnubisMed | 83021-401 | Liquid | Over the counter monograph drugs | November 4, 2022 |
| Anubis Barcelona Protective Line | 83021-686 | Cream | Over the counter monograph drugs | November 2, 2022 |
| AnubisMed | 83021-402 | Liquid | Over the counter monograph drugs | October 26, 2022 |
| AnubisMed | 83021-400 | Liquid | Over the counter monograph drugs | October 26, 2022 |
| Anubis Barcelona | 83021-495 | Concentrate | Over the counter monograph drugs | October 25, 2022 |
| Anubis Barcelona Regul Oil | 83021-740 | Lotion | Over the counter monograph drugs | October 21, 2022 |
| Anubis Barcelona Regul OIl | 83021-624 | Concentrate | Over the counter monograph drugs | October 21, 2022 |
| Anubis Barcelona | 83021-617 | Concentrate | Over the counter monograph drugs | October 21, 2022 |
| Anubis Barcelona Regul Oil | 83021-300 | Cream | Over the counter monograph drugs | October 20, 2022 |
| Anubis Barcelona | 83021-877 | Concentrate | Over the counter monograph drugs | October 19, 2022 |
| Anubis Barcelona Regul Oil | 83021-742 | Cream | Over the counter monograph drugs | October 19, 2022 |
| Anubis Barcelona | 83021-839 | Concentrate | Over the counter monograph drugs | October 18, 2022 |
| Anubismed | 83021-750 | Cream | Over the counter monograph drugs | October 17, 2022 |
| AnubisMed | 83021-551 | Cream | Over the counter monograph drugs | October 15, 2022 |
| Anubis Barcelona Spa Line | 83021-305 | Cream | Over the counter monograph drugs | October 14, 2022 |
| Anubis Barcelona Total Hydrating | 83021-692 | Lotion | Over the counter monograph drugs | October 13, 2022 |
| Anubis Barcelona | 83021-501 | Concentrate | Over the counter monograph drugs | October 13, 2022 |
| Anubis Barcelona New Even | 83021-033 | Lotion | Over the counter monograph drugs | October 13, 2022 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.